BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:44 PM
 | 
Feb 25, 2008
 |  BC Extra  |  Top Story

GTx jumps on Acapodene data

GTx (NASDAQ:GTXI) gained $4.70 (36%) to $17.59 on Monday after reporting that Acapodene toremifene met the primary endpoint in a Phase III trial to treat side effects of androgen deprivation...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >